Next Article in Journal
Transcriptional Regulation of the Human ALDH1A1 Promoter by the Oncogenic Homeoprotein TLX1/HOX11
Previous Article in Journal
The Role of JAK2 Abnormalities in Hematologic Neoplasms
Hematology Reviews (renamed as Hematology Reports here since 2010) is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on as a courtesy and upon agreement with PAGEPress.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Maintenance Therapy in Multiple Myeloma

Jean-Luc Harousseau
Rene Gauducheau Cancer Center, Bd Jacques Monod, CEDEX, 44805 Nantes/St. Herblain, France
Hematol. Rev. 2009, 1(2), e12; (registering DOI)
Submission received: 23 July 2009 / Revised: 30 July 2009 / Accepted: 1 August 2009 / Published: 5 August 2009


Note: In lieu of an abstract, this is an excerpt from the first page.

The treatment of multiple myeloma (MM) has changed dramatically in the past twenty years with the introduction of high-dose therapy plus autologous stem-cell transplantation (ASCT) in younger patients and, more recently, of three novel agents (thalidomide, bortezomib, and lenalidomide) [...]

Share and Cite

MDPI and ACS Style

Harousseau, J.-L. Maintenance Therapy in Multiple Myeloma. Hematol. Rev. 2009, 1, e12.

AMA Style

Harousseau J-L. Maintenance Therapy in Multiple Myeloma. Hematology Reviews. 2009; 1(2):e12.

Chicago/Turabian Style

Harousseau, Jean-Luc. 2009. "Maintenance Therapy in Multiple Myeloma" Hematology Reviews 1, no. 2: e12.

Article Metrics

Back to TopTop